-
Active Ingredient:Paracetamol
-
Content Specification:325mg Paracetamol per 10ml single specification
-
Pharmaceutical Form:Oral Solution
-
Applicable Standard:International pharmacopoeia specification, hospital clinical grade
-
Storage Condition:Sealed storage, protected from light and high temperature, kept in a cool and dry environment
-
Product Features:Precise low-dose formula, stable antipyretic and analgesic efficacy, mild and non-irritating, easy to take, high safety, suitable for clinical routine use and large-scale bulk procurement
Package:
Product Description
Product Overview
Paracetamol Oral Solution 325mg/10ml is a classic mainstream antipyretic and analgesic oral preparation widely used in global clinical practice. It delivers stable fever-reducing and pain-relieving effects with mild gastrointestinal irritation and high safety, suitable for symptomatic treatment of fever and various mild pains in both adults and children.
Paracetamol Oral Solution 325mg/10ml: What the Published Guidance Says
The three non-opioid analgesics named on the WHO Model List — paracetamol, ibuprofen and acetylsalicylic acid — in the full range of oral, rectal and injectable presentations, plus the wider NSAID family.
Paracetamol Oral Solution 325mg/10ml sits in the Analgesics & NSAIDs range. The notes below are the ones that most often change a specification, a label or a tender submission.
- Paracetamol is an antipyretic and analgesic — not an anti-inflammatory The Model List carries a footnote stating paracetamol is not recommended for anti-inflammatory use due to lack of proven benefit to that effect. Marketing copy that positions paracetamol as an anti-inflammatory is inconsistent with the WHO listing. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
- Fever control is part of severe-disease management MSF guidance on severe malaria directs paracetamol in the event of high fever only — a reminder that in febrile illness the antipyretic is supportive care, not the disease treatment. MSF Medical Guidelines — Malaria (Chapter 4.3, Parasitic infections)
- Age limits worth building into your labelling Ibuprofen is not indicated in children less than three months of age according to the Model List. Paediatric paracetamol dosing should follow national formulary weight bands. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
These points are quoted because they shape how Paracetamol Oral Solution 325mg/10ml is specified, labelled and purchased — including strength selection, pack size and the artwork wording. Confirm each one against the approved product information in your market before finalising a purchase order.
Paracetamol Oral Solution 325mg/10ml: Specification, Pack & Documentation Summary
| Therapeutic group | Analgesics & NSAIDs — Analgesics & NSAIDs |
| Manufacturer | Sinophare Bio-technology Co., Ltd. (GMP, China) |
| Documentation supplied | COA, HPLC/GC data, stability data, dossier package |
The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Acetaminophen Oral Solution 1000mg/30ml, Paracetamol Syrup 500mg per 15ml 100ml Bottle, Ibuprofen Suppository 50mg, Indomethacin Suppository 100mg, Naproxen Suppositories 250mg, Paracetamol Suppository 150mg, Diclofenac Sodium 50mg, Mefenamic 250mg Capsules.
How Paracetamol Oral Solution 325mg/10ml Is Tested and Released
Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.
Paracetamol Oral Solution 325mg/10ml is released against the pharmacopoeial monograph named on your order (USP, EP, BP or CP). Where no monograph exists for the exact presentation, the specification is agreed with you in writing before manufacture and is attached to the certificate of analysis.
Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.
Release testing on this presentation is built around:
- Testing for heavy metals and elemental impurities
- Testing for packaging integrity and seal testing
- Testing for description and identification
- Testing for assay of the active substance
- Testing for related substances and impurities
- Testing for dissolution or release profile (solid oral forms)
COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.
How Paracetamol Oral Solution 325mg/10ml Is Packed, Labelled and Shipped
- Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
- Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
- Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.
Regulatory Support for Paracetamol Oral Solution 325mg/10ml
Sinophare Bio-technology Co., Ltd. holds DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. That registration identifies the legal manufacturer on the certificate of analysis, the GMP certificate and the documents filed with your national medicines authority.
- Method validation, stability protocol and the shelf-life justification for the marketed pack.
- Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
- Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
- Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.
- Batch manufacturing and packaging records released for inspection on request during supplier audits.
This page describes Paracetamol Oral Solution 325mg/10ml as a product of the non-opioid analgesics and NSAIDs named in the WHO Model List family. A WHO or national listing is a supply-context fact, not an approval in your market; marketing authorisation remains specific to each country.
Questions We Are Asked About Paracetamol Oral Solution 325mg/10ml
How is Paracetamol Oral Solution 325mg/10ml packaged?
Syrup presentations are quoted to your pack specification, with the artwork, pack size and labelling language confirmed before manufacture.
What documentation comes with a shipment of Paracetamol Oral Solution 325mg/10ml?
Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 36 months.
Does the batch documentation for Paracetamol Oral Solution 325mg/10ml support a registration filing?
Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.
Is diclofenac on the WHO Essential Medicines List?
No. The non-opioid analgesics named in section 2.1 are acetylsalicylic acid, ibuprofen and paracetamol. We supply diclofenac sodium in injectable and capsule form for markets whose national lists include it.
Can you supply sustained-release or combination analgesics?
Yes — including compound presentations and sustained-release forms. Confirm the specific combination against your national registration before ordering.
Companion Products — Analgesics & NSAIDs
- Acetaminophen Oral Solution 1000mg/30ml — 1000mg
- Paracetamol Syrup 500mg per 15ml 100ml Bottle — 500mg
- Ibuprofen Suppository 50mg — 50mg
- Indomethacin Suppository 100mg — 100mg
- Naproxen Suppositories 250mg — 250mg
- Paracetamol Suppository 150mg — 150mg
Browse the full Analgesics & NSAIDs range; all Syrups; the complete product catalogue.
Request a Quotation for Paracetamol Oral Solution 325mg/10ml
Send the specification, pack size, quantity and destination market for Paracetamol Oral Solution 325mg/10ml 325mg/10ml and we will confirm availability, lead time and documentation. Tender quantities and registration samples are handled on the same quotation.
Sources & Regulatory Notes
- WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
- MSF Medical Guidelines — Malaria (Chapter 4.3, Parasitic infections)
Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.
